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Our aim was to determine the most effective surgical treatment for arteriovenous fistula
(AVF) complications after all other methods of salvage have failed. We evaluated 110
patients for 139 complications that occurred after the initial AVF placement and for
whom surgical intervention was the last hope for retaining fistula access. Vascular steal
syndrome and venous hypertension were the most common complications seen in our
patients. The anastomoses of 17 of the vascular steal syndrome cases were narrowed
either by stitches or by a polytetrafluoroethylene graft. The second most performed
revision surgery was excision of the aneurysm and repair with primary suturing,
followed by excision of the aneurysm and interposition grafting. Successful surgical
outcomes were achieved in 111 of 139 procedures after revision surgery without
constructing a new AVF. AVF salvage surgery is of paramount importance in order to
increase the patency rate, which prolongs survival and increases the patient’s quality of
life.
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Because survival rates in patients with end-stagerenal disease have been rising because of
developments in treatment procedures, the impor-
tance of sustained vascular access for hemodialysis
has increased.1
Many late complications, such as (1) thrombosis,
(2) venous hypertension, (3) aneurysm/pseudoan-
eurysm formation, (4) hemorrhage, (5) vascular steal
syndrome (VSS), (6) stenosis, and (7) heart failure
may occur following arteriovenous fistula (AVF)
surgery.1,2 These may cause dysfunction of the AVF
and limit the efficiency of hemodialysis.
Our aim in this retrospective analysis is to present
our experience in the surgical treatment of AVF
complications in patients for whom all other
conservative treatment methods of salvage have
Corresponding author: Sedat Belli, MD, Department of Surgery, Adana Baskent Medical and Research Center, 1250 Adana, Turkey.
Tel.: þ90 3223272727; Fax: þ90 3223271276; E-mail: bellisedat@gmail.com
Int Surg 2014;99 467
failed. These include radiologic interventions, such
as covered stent; coil embolization; application of
thrombin or percutaneous transluminal angioplasty
balloon dilatation; thromboaspiration; and throm-
bolysis. Our study contributes to the literature
because data on successful surgical salvage tech-
niques for AVFs are limited, despite the relative high
frequency of documented AVF complications. Our
study focuses on surgical solutions, in particular
highlighting minor factors that can increase the
success of surgical interventions for compromised
AVFs. For this study we examined the clinical
presentations and surgical techniques for treating
these complications and postintervention outcomes.
Patients and Methods
Patient selection and evaluation
This is a retrospective review of all patients who
underwent surgical repair for late complications of
their AVFs at our center for 10 years, from January
2001 until December 2010. A total of 1558 AVF-
related surgeries were performed in our center
during the study period. We evaluated 110 patients
for 139 complications that occurred after the initial
AVF placement. For the patients in the current study
group, surgical intervention was the last hope for
retaining fistula access, because all other conserva-
tive treatment methods of AVF salvage, as notified
above, had failed.
Patient demographic data include age, sex, hyper-
tension, diabetes mellitus, coronary artery disease,
congestive cardiac failure, smoking, use of anticoag-
ulants, region of fistula insertion, the number of
fistulas, fistula-related complications, mode of pre-
sentation, and surgical technique used for restorative
surgery. Furthermore, all of the outcomes were
collected from our center’s medical records.
The study was approved by the Baskent Univer-
sity Institutional Review Board (project no. KA13/
27) and by the Baskent University Research Fund.
All patients seen at our center for AVF-related
complications are first evaluated by the general
surgery department, where the preoperative assess-
ment described below is carried out. After this
initial assessment, all patients, with the exception of
those admitted in critical condition, are referred to
the interventional radiology department. The pa-
tients selected as cases were subjected to initial
procedures in which various endovascular methods
were applied; however, there appeared such com-
plications as aneurysm thrombosis, and shortness of
the potential cannulation due to partial aneurysm
thrombosis.
Once the patients are treated through endovas-
cular methods, as a final option the patients return
to the general surgery department. As a result, we
aimed to perform certain kinds of operations, such
as narrowing by nonabsorbable sutures or small-
caliber interposition grafts, excision of the aneurysm
and repair with primary suturing, narrowing the
outflow vein with a tight polytetrafluoroethylene
cuff, ligation of the patent distal vein branch, graft
interposition, basilic vein transposition, thrombec-
tomy, and hemostasis (repair with primary suturing
or autogenous veins grafts), which would reach
efficient outcomes because there would be no need
to create new fistulas. Criteria of AVF complications
considered for surgical revision are described in
Table 1. Some of these complications are shown in
Fig. 1.
Preoperative assessment
The preoperative clinical evaluation includes a color
duplex Doppler ultrasound (CDDUS). If there is a
suggestion of central stenosis, a fistulogram is
performed for further evaluation. This preoperative
protocol was carried out on all patients in our study
group.
Postoperative follow-up
As is routine in our center for these surgical
interventions, heparin (50–100 U/kg body weight)
was administered intravenously, and a heparin
infusion was continued for 24 hours after the
revision surgery. When patients were discharged
from the hospital, a low dose of aspirin or
dipyridamole was prescribed to be used at home.
Patients were examined for the first time 1 month
after discharge, and after this initial follow-up
patients were examined within 6 and 12 months.
Table 1 Criteria of AVF complications are considered for surgical
revision
a. Exposed graft with overlying skin erosion
b. Signs of local infection (erythematic, purulent discharge, or a
draining sinus tract)
c. Aneurysm formation
1. Pain in the area overlying
2. Rapidly expanding aneurysm (.2 cm/6 months)
3. Thrombosis of the aneurysm
d. Ulceration and bleeding
e. Loss of adequate cannulation segment
f. Central stenosis
BELLI SURGICAL INTERVENTIONS FOR LATE AVF COMPLICATIONS
468 Int Surg 2014;99
The final follow-up was performed 24 months after
the patients were discharged. The patients were
examined by the surgery department with CDDUS
scans. The corrected AVFs were assessed for
functionality, and patency rates were noted.
The postintervention patency status was assessed
according to the standards of the Society of Vascular
Surgery and the Society of Interventional Radiology.
In the follow-up period, a failing AVF was defined
as a patent access that was functioning poorly
because of hemodynamically significant stenosis
(.50%) as documented by CDDUS.3 A patent AVF
with normal blood flow may be inefficient for
hemodialysis because of other problems, such as
outflow vein or in-graft aneurysms without stenosis
showing a risk for rupture, infection, or steal
syndrome. In these cases, this was also considered
as a failing or nonfunctional AVF.3
Statistical methods
Statistical analyses were performed using Statistical
Package for the Social Sciences software (version
16.0, SSPS Inc, Chicago, Illinois). Chi-square analysis
was used to assess categoric variables. Mann-
Whitney U test was used to analyze continuous
variables. Categoric variables were expressed as
absolute values and percentages. The Kaplan-Meier
analysis was used to evaluate patency rates. P ,
0.05 was considered statistically significant.
Results
During the study period 110 patients were treated
for complications. The demographics and systemic
concomitant diseases are detailed in Table 2. The
mean duration of renal failure was 49.3 6 40.6
months (range, 1–180 months). A total of 92 (66.2%)
of the AVFs with complications had their index
surgical procedures performed at other surgical
facilities. The mean number of previously per-
formed AVFs per patient was 2.1 6 1.2 (range, 1–
7). Most of the complications were detected in AVFs
with native vessels and in brachiocephalic fistulas
(Table 3).
Fig. 1 (a and b) Photograph of an
infected pseudoaneurysm. (c) Giant
brachial artery aneurysm in the left arm.
(d) Dilation of the cephalic vein with a
brachial artery aneurysm in the left
upper arm.
Table 2 Patients’ characteristics and demographics
Variable Value
Age, y, mean 6 SD (range) 48.5 6 17.4 (13–78)
.50 y, n (%) 81 (58.3)
Female sex, n (%) 58 (52.7)
Hypertension, n (%) 67 (48.2)
Diabetes mellitus, n (%) 51 (36.7)
Coronary artery disease, n (%) 7 (5)
Congestive cardiac failure, n (%) 3 (2.1)
Smoking, n (%) 52 (47.2)
Anticoagulant use, n (%)a 46 (41.8)
aPatients who have their initial access at our center are
routinely treated with anticoagulants; however, the number is
low in our series because of the large number of patients who had
their initial access in other centers.
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The complications in AVFs performed in the
proximal elbow region were more common (Table
4). The surgical procedures performed for each
complication type are summarized in Table 4.
Although our general strategy was to salvage the
AVF, conditions such as life-threatening bleeding,
severe ischemia, infection, or ulcerations required
the closure of the access (Fig. 1a and 1b).
Severe bleeding and failure of the revised AVF
were the most common complications encountered
after salvage surgery (Table 5). A total of 80% of the
original AVFs were functional after the revision
surgery; in the rest, a new AVF was created during
the same session.
The mean follow-up was 16 months, with a range
of 1 to 69 months. Postintervention primary paten-
cies for all revised AVFs were 80%, 72%, 56%, and
38% at 1, 6, 12, and 24 months, respectively.
Demographic characteristics, synthetic graft use,
comorbid systemic diseases, complications after
Table 3 Type of vascular access and the number of accesses before the corrective surgery
Variable Patients, n (%) No. of procedures (%)a
Type of vascular access
Brachial-cephalic fistula (antecubital) 62 (56.4) 80 (57.6)
Brachial-basilic fistula (antecubital) 12 (10.9) 12 (8.6)
Radial-cephalic fistula (Brescia-Cimino) 20 (18.2) 27 (19.4)
Radial-cephalic fistula (snuff-box) 8 (7.3) 12 (8.6)
Upper arm loop PTFE graft 4 (3.6) 4 (2.9)
Upper arm straight PTFE graft 1 (0.9) 1 (0.7)
Lower limb loop PTFE graft 3 (2.7) 3 (2.2)
No. of previously performed AVFs
1 44 (40) 54 (39.4)
2 35 (32) 46 (33.6)
.2 31 (28) 39 (27)
Native AVF 102 (92.7) 131 (94.3)
Prosthetic AVF 8 (7.3) 8 (5.7)
Total 110 139
PTFE, polytetrafluoroethylene.
aSome patients had more than one procedure.
Table 4 Distribution of complication types due to AVF locations and surgeries performed on AVF complications
Type of complications (n)
Site of AVF, n (%)
Surgical procedure (n)
Proximal
(elbow)
Distal
(wrist)
Lower
limb
Vascular steal syndrome (35)a 26 (74.3) 9 (25.7) 0 (0) Narrowing by nonabsorbable sutures or small-caliber
interposition grafts (17)
Ligation of the fistula (11)
Narrowing the outflow vein with a tight PTFE cuff (7)
Venous hypertension (35) 21 (60) 14 (40) 0 (0) Ligation of the patent distal vein branch (31)
Ligation of the fistula (4)
Aneurysm/pseudoaneurysm
formation (31)
22 (71) 7 (22.6) 2 (6.4) Excision of the aneurysm and repair with primary suturing
(14)
Interposition grafting (12)
Ligation of the fistula (5)
Bleeding (13) 12 (92.3) 1 (7.7) 0 (0) Hemostasis (repair with primary suturing or autogenous
vein grafts) (8)
Ligation of the fistula (5)
Dysfunction of AVF (12) 12 (100) 0 (0) 0 (0) Basilic vein transposition (12)
Thrombosis (11) 7 (64) 3 (27) 1 (9) Thrombectomy (11)
Ligation of the fistula (3)
High-output cardiac failure (2) 2 (100) 0 (0) 0 (0) Narrowing the outflow vein with a PTFE graft (2)
Total (%) 102 (73.4) 34 (24.5) 3 (2.1) 139 (100%)
PTFE, polytetrafluoroethylene.
aThirteen of these cases underwent emergency surgery because of severe ischemia.
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surgery, and the complication period had no effects
on fistula patency (P . 0.05).
Discussıon
Because of insufficient numbers of kidney donors
and difficulties in achieving optimal hygienic
conditions for peritoneal dialysis, performing AVFs
for periodic hemodialysis has become the first
choice of patients with chronic renal failure,
performed on more than 65% of patients in 2008 in
the United States.4,5 The importance of vascular
access for hemodialysis has increased because of the
increasing number of patients surviving longer with
chronic renal failure.6 Although the use of prosthetic
grafts and the application of central venous cathe-
ters are effective, the first choice for vascular access
surgeons is the radiocephalic wrist fistula because of
its practical use and low complication rates com-
pared with other vascular access methods.7–9
Several systemic and/or local complications can
occur at various stages after performing AVFs.10–13
The prevalence of these complications has been
reported as ranging from 11.4% to 64% in different
studies.14–16 In this study we have included only the
patients for whom surgical interventions were
absolutely necessary; however, many of these
complications can generally be treated by radiologic
intervention. If the 92 patients whose initial access
was performed in other centers were excluded, then
the long-term complication rate of the AVFs per-
formed in our center was only 3.3%, which is
comparably lower than those in the other published
studies. Some measures have been found to de-
crease AVF-related complications in patients who
have end-stage renal disease in our center. These
measures include preferring vessels from distal to
proximal when evaluating the location for AVFs in
the upper extremity, using native vessels, if possible,
providing experienced health care professionals in
the hemodialysis units, and education of patients,
respectively.
Difficulties in vascular access are one of the most
important causes of morbidity and mortality in
patients who have chronic renal failure.10 The risk
factors for increased AVF-related complications have
been found to include female sex, being of African
descent, having diabetes or cardiovascular diseases,
having a smoking habit, and being older than 50
years.10,17 However, in our patient population well-
established proatherogenic factors did not influence
the risk of AVF complications. Furthermore, we
found that sex distribution was not a major factor
(Table 2). As in the study by Salahi et al,10 we found
that complication rates increased with age.
VSS was one of the two most encountered AVF
complications in our study. It is likely that the steal
syndrome will disappear after the access is aban-
doned, yet creation of a new AV access on another
extremity is burdened with a high amount risk of
recurring peripheral ischemia. Thus, correction of
the steal syndrome is to aim at the double goal of
preserving the access while improving peripheral
arterial circulation. The incidence of ‘‘late’’ VSS is
reported to mainly be connected to the location of
the AVF. For instance, VSS is reported rarely in AVFs
located in the wrist (0.25%), whereas it is more
commonly reported in wide brachiocephalic AVFs
(10%–20%).12,13 We had similar results in our study
with regard to location as a critical factor; moreover,
we observed that the onset of VSS was found to
occur more readily in fistulas with large anastomo-
ses and high flows. In the current study, the
percentage of VSSs was 25.1%, all of which occurred
in upper extremities. Severe ischemia with nerve
damage due to VSS is an emergency and its reported
prevalence was 3.9%.18,19 In our group, emergency
surgery due to severe ischemia was necessary in 13
cases (11.8%). The outflow resistance of these AVFs
was increased by various methods to direct the
blood flow to the distal artery (Table 4).
Table 5 Additional complications encountered after management of the initial complication
Complication Procedure, n (%) Management
Failure of the revised AVF 28 (20.1) Creation of new AVF
Severe bleeding 7 (5) Stenting, coil embolization, or primary suturing
Stenosis 5 (3.6) Central venous angioplasty or stenting
Thrombus 3 (2.1) TPA treatment
Graft rupture 1 (0.7) Repair with autogenous grafts
Surgical site infection 1 (0.7) Percutaneous drainage and systemic antibiotic treatment
Total 45 (32.2)
TPA, tissue plasminogen activator.
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The other most common complication was venous
hypertension. It usually results from central vein
stenosis and/or thrombosis secondary to previous
catheterization or valvular incompetence in the AVF
outflow vein.20 Another significant cause is unim-
peded flow to the distal venous part of the extremity,
which is caused by non-ligation of the distal venous
part of the anastomosis. In our center effective
treatment was achieved by ligation of the distended
vein, which was located in the distal part of the AVF
in 31 of the 35 patients (88.6%) who had severe
edema in their upper extremities. We observed that
all of these patients’ first AVFs had been performed
in other centers by the side-to-side technique without
the distal venous part ligated. Beigi et al21 reported
that ligation of the distal vein when using the side-to-
side technique prevented venous hypertension. In
the remaining 4 patients whose index operations
were performed by us, additional collateral veins
appeared in time, even though the distal vein of the
anastomosis was ligated.
Aneurysm/pseudoaneurysm formation is one of
the main late-term complications after AVF forma-
tion, occurring in from 2% to 10% of patients.10 In
our series the complication ratio in the general
population with fistulas was 1.98%, whereas the
patient ratio in the complication group was 22.3%.
These complications can result in significant life-
threatening events, such as rupture, bleeding, or
access dysfunction and thrombosis (Fig. 1c and 1d).
Traditionally, surgical repair of these aneurysms
involves either ligation or resection; however, in this
study the surgical aim was to salvage the access.22–25
In a large study including 44 aneurysms involving
both AVF and grafts, Georgiadis et al22 reported that
the mean primary patency after salvage at 24
months is 32%. Our salvage rate for this type of
complication was 83.9% (26 of 31). We used excision
of the aneurysm and repair with primary suturing
(n¼ 14) and interposition grafting (n¼ 12); the long-
lasting patency of these 26 salvaged AVFs (44% at 24
months) has encouraged us to continue using these
type of interventions rather than ligation.
Bleeding and/or rupture of the AVF from needle
access after hemodialysis can be a serious compli-
cation that may be lethal if immediate intervention
is not initiated. Of all complications requiring
surgery, the rate of this complication has been
reported as between 1.2% and 4.6%10,12,16 In our
group it was observed in 13 patients (9.3%) and
hemostasis was achieved by using primary sutures
or autogenous vein grafts in 8 patients (Table 4).
AVFs had to be closed in the remaining 5 patients
through ligation.
A dysfunctional AVF can occur when the blood
flow is misdirected. Although cephalic vein outflow
was targeted, in some patients the flow was directed
to the basilic vein, which resulted in inadequate
hemodialysis, even though the AVF was technically
functioning. In order to use these AVFs, basilic vein
transposition was performed on these patients.
Hemodialysis was successful in all patients on
whom vein transposition was performed; however,
in the case of a nonfunctioning cephalic vein, direct
brachiobasilic AVFs may be advisable. In their
prospective clinical studies Karakayali et al26 rec-
ommend that brachiobasilic AVFs and transposition
at the same session should have low morbidity, high
maturation, and high patency rates, so they should
be used as a first-choice solution in situations such
as the absence of the cephalic vein.
Thrombosis as a late complication may signifi-
cantly decrease the patency rate of AVFs. In patients
with thromboses, surgical revision generally results
in only 25% to 50% patency.15 In our series the
secondary patency was 70% after thrombectomy
during the early postoperative period.
The quality of the initial access as well as the use
of the AVF is significant in determining the severity
and rate of complications. As is the case with most
diseases, prevention is better than treatment. To
limit complications, our surgical protocol for initial
AVF placement is to use preoperative ultrasono-
graphic mapping or venography to choose appro-
priate vessels (diameter .2 mm) located in the
distal arm for AVF creation.27 The surgeons ensure
that the anastomotic diameter is not greater than 5
mm and distal vein is ligated in order to prevent
venous hypertension and high output. This surgical
approach combined with trained hemodialysis
personnel using the access results in fewer compli-
cations, as the data collected from our study showed
[our complication rate was 3.3% (47 of 1419)
compared with 11.4% to 64% from other studies],
and allows the initial AVF to function longer.
Most of the patients included in our study had
already undergone surgical operations at different
centers, and they were categorized as the patients
with severe complications because they had no
options in terms of endovascular intervention.
Therefore, in this study we have included only the
patients on whom endovascular intervention was
not an option and surgical interventions were
necessary. The retrospective descriptive nature of
this study is the main limitation. Because our center
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is a reference center and patients’ chronic renal
failure duration is longer, such reference rates seem
to be higher than the average. Although a good
number of patients and procedures were analyzed
in the pool, it is hard to isolate a direct causative
effect for the occurrence of AVF complications. In
addition, the number of patients seems to be
sufficient, because they had no record; the patients
who had already undergone endovascular interven-
tion were not included in the study. Moreover,
because a successful radiologic intervention was
performed on them, they did not need surgery;
therefore, we did not include them in the current
study.
Even with the appropriate selection of vessel and
anatomic site, where normal anatomy changes
permanently, as it does in all AVF surgeries,
complications are inevitable. Under these conditions
every effort should be made to salvage the func-
tioning AVF in order to save virgin vessels for future
use. To this end, patients with these complications
may be referred to a top-rated tertiary center in the
hope that the original AVF has the highest possible
chance of being salvaged.
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